Logo image of FLJ

FLJ GROUP LTD-ADR (FLJ) Stock Fundamental Analysis

NASDAQ:FLJ - Nasdaq - US74738J3005 - ADR - Currency: USD

0.8195  +0.07 (+8.95%)

After market: 0.7478 -0.07 (-8.75%)

Fundamental Rating

1

Taking everything into account, FLJ scores 1 out of 10 in our fundamental rating. FLJ was compared to 64 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of FLJ have multiple concerns. FLJ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FLJ has reported negative net income.
In the past year FLJ has reported a negative cash flow from operations.
FLJ had negative earnings in 4 of the past 5 years.
In the past 5 years FLJ reported 4 times negative operating cash flow.
FLJ Yearly Net Income VS EBIT VS OCF VS FCFFLJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B -1.5B

1.2 Ratios

The Return On Assets of FLJ (-133.84%) is worse than 95.31% of its industry peers.
Industry RankSector Rank
ROA -133.84%
ROE N/A
ROIC N/A
ROA(3y)208.21%
ROA(5y)79.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FLJ Yearly ROA, ROE, ROICFLJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 200 400 600 800

1.3 Margins

FLJ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FLJ Yearly Profit, Operating, Gross MarginsFLJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

More info and screens

2

2. Health

2.1 Basic Checks

FLJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
FLJ has more shares outstanding than it did 1 year ago.
FLJ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FLJ has been reduced compared to a year ago.
FLJ Yearly Shares OutstandingFLJ Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 500B 1T 1.5T 2T 2.5T
FLJ Yearly Total Debt VS Total AssetsFLJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 13791.04 indicates that FLJ is not in any danger for bankruptcy at the moment.
FLJ's Altman-Z score of 13791.04 is amongst the best of the industry. FLJ outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 13791.04
ROIC/WACCN/A
WACC4.41%
FLJ Yearly LT Debt VS Equity VS FCFFLJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -1B -2B

2.3 Liquidity

FLJ has a Current Ratio of 0.12. This is a bad value and indicates that FLJ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.12, FLJ is doing worse than 92.19% of the companies in the same industry.
A Quick Ratio of 0.12 indicates that FLJ may have some problems paying its short term obligations.
The Quick ratio of FLJ (0.12) is worse than 92.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
FLJ Yearly Current Assets VS Current LiabilitesFLJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.
The Revenue for FLJ has decreased by -45.18% in the past year. This is quite bad
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.92%
Revenue 1Y (TTM)-45.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FLJ Yearly Revenue VS EstimatesFLJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 500M 1B 1.5B
FLJ Yearly EPS VS EstimatesFLJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 -1K -2K -3K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
FLJ Price Earnings VS Forward Price EarningsFLJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLJ Per share dataFLJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0 0 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FLJ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FLJ GROUP LTD-ADR

NASDAQ:FLJ (5/29/2024, 8:03:33 PM)

After market: 0.7478 -0.07 (-8.75%)

0.8195

+0.07 (+8.95%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-26 2024-02-26
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change-51.31%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2325.65B
Analysts45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 84343.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -133.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)208.21%
ROA(5y)79.92%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 13791.04
F-Score3
WACC4.41%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-45.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.7%
OCF growth 3YN/A
OCF growth 5YN/A